Sanofi (NASDAQ:SNY – Get Free Report) saw a large growth in short interest in June. As of June 15th, there was short interest totalling 7,820,000 shares, a growth of 51.6% from the May 31st total of 5,160,000 shares. Approximately 0.3% of the company’s stock are short sold. Based on an average daily volume of 2,410,000 shares, the short-interest ratio is currently 3.2 days.
Sanofi Stock Performance
Shares of SNY stock traded up $1.07 during trading on Monday, reaching $49.59. The company had a trading volume of 3,045,270 shares, compared to its average volume of 2,119,382. The company has a market capitalization of $125.60 billion, a PE ratio of 24.92, a PEG ratio of 1.50 and a beta of 0.59. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.27 and a quick ratio of 0.87. The firm’s 50 day simple moving average is $48.68 and its two-hundred day simple moving average is $48.57. Sanofi has a one year low of $42.63 and a one year high of $55.72.
Sanofi (NASDAQ:SNY – Get Free Report) last posted its earnings results on Thursday, April 25th. The company reported $0.96 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.96. The business had revenue of $11.36 billion for the quarter, compared to analyst estimates of $11.75 billion. Sanofi had a net margin of 10.52% and a return on equity of 26.25%. Sell-side analysts forecast that Sanofi will post 4.13 earnings per share for the current year.
Institutional Investors Weigh In On Sanofi
About Sanofi
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.
Read More
- Five stocks we like better than Sanofi
- What is a Dividend King?
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- How to Invest in Insurance Companies: A Guide
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- What is the Shanghai Stock Exchange Composite Index?
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.